BN Business News
会社を追加 →
この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。

規制と法律 · 1996/12/161 分で読めます

Anticaries Drug Products for Over-the-Counter Human Use; Partial Stay of Final Rule; Enforcement Policy

ローカル自動翻訳 · 情報源の原言語

概要

The Food and Drug Administration (FDA) is staying part of a final rule that established conditions under which over-the-counter (OTC) anticaries drug products (products that aid in the prevention of dental cavities) are generally recognized as safe and effective and not misbranded (60 FR 52474, October 6, 1995). This final rule stays the testing procedures for fluoride dentifrice drug products to provide manufacturers an additional 12 months to comply with these testing requirements. This action is being taken in response to a citizen petition requesting this stay and is part of the ongoing review of OTC drug products conducted by FDA.

情報源の原言語: Federal Register — All Documents原文の発表を開く →

関連インサイト

ビジネスインサイト →